-
FDA Approves USAntibiotics’ Augmentin XR in Historic First for Expedited Review Program
-
USAntibiotics Awarded FDA National Priority Voucher for Domestic Manufacturing of Critical Antibiotic
-
USAntibiotics Working with Walmart and McKesson to Support U.S. Manufacturing of Amoxicillin
-
USAntibiotics Names Mark Tengler Senior Vice President of Manufacturing Technologies
-
USAntibiotics Expands Leadership Team with Appointment of Steven Lutz to Vice President of Strategic Accounts
-
As Amoxicillin Shortage Continues, USAntibiotics Urges Lawmakers to Consider Policies and Partnerships That Support U.S. Drug Manufacturers
-
USAntibiotics Stands Ready to Assist in Critical Amoxicillin Shortage
-
USAntibiotics, the Nation’s Sole Amoxicillin Manufacturing Facility, Launches Production to Secure Critical Supply Chain
-
USAntibiotics Appoints Company President to Lead Operations at Nation’s Only Antibiotics Manufacturer of Amoxicillin Products
-
USAntibiotics Reopens Facility and Returns Antibiotic Production to the United States from China
